KNect365 is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


BioPharm America™ 2017: Xontogeny fills unique niche in biotech market

Chris Garabedian is the chairman and CEO of Boston-based Xontogeny. It calls itself a 'biotech aggregator,' which is one way to describe the process of bringing scientific entrepreneurs, ideas, and capital together into fledgling biotech companies. Speaking at BioPharm America™ in Boston, Garabedian described the niche he sees for Xontogeny in the market, and why it's often overlooked by traditional venture capital.

Get the latest news as it happens.